ÌÇÐÄÔ­´´

Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a new study from a collaboration across the Universities of Manchester, Nottingham, Edinburgh and Dundee.

New research has found that a natural predatory bacteria, long known to target its prey by burrowing inside of them, is actually able to kill by delivering a ‘kiss of death, meaning it doesn’t have to live inside its prey to kill it, as previously thought.

Scientists at the ÌÇÐÄÔ­´´ have discovered that prostate cancer is able to spread through a man’s body by taking off the genetic ‘handbrake’ that stops cells growing out of control — and a new project will now work out how to put the brakes back on.

A new study has found that nursing students’ compassion is not increased by previous paid care experience, which discredits the idea that they should have care experience before embarking on training

Experts at the ÌÇÐÄÔ­´´ are joining forces with Stand Against MND and the MND Association, to carry out research to better understand motor neurone disease (MND) mechanisms – the biochemical processes that go wrong – in order to speed up the race to find new treatments.

A third-year learning disability nursing student from the ÌÇÐÄÔ­´´ has developed a resource for healthcare workers to help them use Makaton when communicating with patients who have learning or communication difficulties.

A group of leading scientists from the ÌÇÐÄÔ­´´ are part of a global, interdisciplinary team of experts who will be taking on cancer inequities, thanks to a Cancer Grand Challenges award.

Academics from the ÌÇÐÄÔ­´´ joined paramedics and firefighters this week for a road traffic collision (RTC) exercise to help health science students to better understand a patient’s journey from road to hospital.

A ÌÇÐÄÔ­´´ spin-out that is developing a new treatment for patients with cardiovascular disease, has raised £7.5m in funding.

The ÌÇÐÄÔ­´´ will lead a national hub that will develop vaccines, diagnostics and therapeutics, benefiting millions of people worldwide, thanks to funding from UK Research and Innovation (UKRI).